Intralymphatic immunotherapy with birch and grass pollen extracts. A randomized double-blind placebo-controlled clinical trial.

Lars AhlbeckEmelie AhlbergLinn StuiversJanne BjörkanderUlla NyströmPavlos RetsasDhanapal GovindarajMaria C JenmalmKarel Duchén

Published in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2023)

In this randomized controlled trial, ILIT with birch and grass pollen extract was safe and accompanied by immunological changes. Further studies are required to confirm or refute the efficacy of the treatment.

Keyphrases

double blind
placebo controlled
clinical trial
study protocol
randomized controlled trial
phase ii
phase iii
oxidative stress
open label
radiation therapy
replacement therapy
anti inflammatory
case control
cell wall